A surgical chip is a recognizing coordinated circuit gadget / RFID transponder encased in silicate glass and embedded in the body of a person. A sub dermal implant ordinarily contains an exceptional ID number that can be connected to data contained in an outside database, for example, individual recognizable proof, medicinal history, meds, allergies, and contact information. The global market for Surgical Chips is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%
Key Players for Surgical Chips Market:
Some of the key players in this market are: Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer, Inc. (US) Fluidigm Corporation (US) Illumina, Inc. (US) GE Healthcare (UK) Bio-Rad Laboratories Inc. (US) Cepheid (US), Thermo Fisher Scientific, Inc. (US) Roche Diagnostics (Switzerland)
Segments:
Global Surgical Chips market has been segmented on the basis of types which comprises of DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of application which consists of Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics and others